Mometasone Furoate Market Size & Share by Dosage Form (Nasal Spray, Cream, Ointment, Inhalers); Indication (Inflammatory Skin Disorders, Asthma, Allergic Rhinitis); Route of Administration (Nasal, Topical, Oral); Distribution Channel (Hospital, Retail, Online) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5507
  • Published Date: Jan 05, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Mometasone Furoate Market size is anticipated to cross USD 3 Billion by the end of 2036, growing at a CAGR of 7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of mometasone furoate was over USD 1 Billion. The increasing prevalence of asthma worldwide is expected to witness significant growth in the forecast period. As per a report, each year, asthma claims the lives of about 3,500 people, almost half of whom are 65 years of age or older. According to recent statistics, children (53%) are more likely than adults (44.9%) to experience an asthma attack, with half of those who have the condition experiencing at least one annual episode. Therefore, the growing cases of asthma are positively impacting the growth of the market.

Furthermore, the rising awareness and focus on skincare and overall well-being have played a role in driving the mometasone furoate market. People are becoming more conscious of taking care of their skin and seeking professional advice when needed. This has increased the demand for dermatological treatments like mometasone furoate. Also, the expansion of the aging population worldwide is contributing to the growth of the market.

Mometasone Furoate Market
Get more information on this report: Request Free Sample PDF

Mometasone Furoate Market: Key Insights

Base Year


Forecast Year



~ 7%

Base Year Market Size (2023)

~ USD 1 Billion

Forecast Year Market Size (2036)

~ USD 3 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Mometasone Furoate Market: Growth Drivers and Challenges


Growth Drivers

  • Increasing Research and Development Activities - Over the course of the forecast period, rising mometasone furoate-related research and development efforts are anticipated to propel market expansion. As per a recent study in 2021, one of the most important components of treatment for patients with eosinophilic esophagitis is topical corticosteroids. The purpose of this study was to examine the benefit of utilizing mometasone furoate spray versus placebo on dysphagia and health-related quality of life in these patients.
  • Increasing Product Launches - Over the course of the forecast period, the worldwide mometasone furoate market is anticipated to rise as a result of an increase in product launches and market player approvals. For instance, in 2020, Enerzair® Breezhaler® (QVM149; indacaterol acetate, glycopyrronium bromide, and mometasone furoate [IND/GLY/MF]) was approved by the European Commission (EC) to treat adult patients with asthma who have not had their asthma adequately controlled with a maintenance regimen that includes a long-acting beta2 agonist (LABA) and a high-dose inhaled corticosteroid (ICS) and who have had one or more asthma exacerbations in the preceding year. Novartis made this announcement in July 2020.
  • Growing Cases of Respiratory Allergies - Respiratory allergies can result from more generalized reactivity to irritants like smoke and fumes in both indoor and outdoor environments, which can exacerbate allergy symptoms, or from particular allergic reactions. By influencing the immune system, mometasone lessens the appearance of redness, swelling, and itching, which are signs of allergic reactions and inflammatory diseases. The patient’s nose's puffiness and mucous are reduced with the nasal spray. Although the effects last longer than those of antihistamine sprays, it may take a little longer to start working. Therefore, the growing prevalence of respiratory allergies globally is also accelerating the market growth.


  • Severe Side Effects – Some of the common side effects of mometasone are allergic reactions, nausea, vomiting, loss of appetite, and headache. On the other hand, some severe side effects that may negatively impact the growth of the market are crusting, blurry vision or vision loss, and white patches in the nose or mouth. Therefore, the severe side effects may adversely hamper the growth of the mometasone furoate market.
  • Competition from Alternative Drugs May Hamper the Growth of the Market
  • Strict Regulatory Requirements and Approval Processes May Hinder the Growth of Mometasone Furoate Market

Mometasone Furoate Segmentation

Indication (Inflammatory Skin Disorders, Asthma, Allergic Rhinitis)

Mometasone furoate market for the allergic rhinitis segment is anticipated to hold the largest share of 45% during the projected period. The demand for quicker and higher-quality diagnostic techniques is projected to rise in tandem with rising healthcare costs. This will present significant potential prospects for companies in the worldwide market for the treatment of perennial allergic rhinitis. In addition to the enormous financial burden that respiratory disease places on society due to disability and early death, it also raises costs for prescription drugs, direct health care, and indirect costs associated with lost productivity. Treatment for allergic asthma is often required in conjunction with perennial allergic rhinitis. The market for treatments for allergic rhinitis is also being impacted by this illness worldwide. Moreover, mometasone nasal spray is frequently recommended to help reduce allergic rhinitis symptoms. The expansion of this market segment can be attributed to mometasone's efficacy in treating allergic rhinitis.

Route of Administration (Nasal, Topical, Oral)

The topical segment in the mometasone furoate market is anticipated to hold a share of 43% during the projected period. The growth of the segment can be attributed to the growing prevalence of skin conditions like eczema, psoriasis, and dermatitis worldwide. As per a report, about 223 million people (including 43 million children and young adults) worldwide suffered from atopic dermatitis in 2022. This demonstrates the remarkably elevated occurrence in early children. Mometasone furoate in the form of creams, ointments, and lotions, has shown great efficacy in managing these conditions, leading to its popularity among healthcare professionals and patients. Also, the convenience and ease of use of topical formulations have contributed to their expansion. Furthermore, advancements in formulation technology have improved the delivery and absorption of mometasone furoate through the skin, enhancing its efficacy. Therefore, these innovations have led to the expansion of the topical segment.

Our in-depth analysis of the global mometasone furoate market includes the following segments:

          Dosage Form

  • Nasal Spray
  • Cream
  • Ointment
  • Inhalers


  • Inflammatory Skin Disorders
  • Asthma
  • Allergic Rhinitis

          Route of Distribution

  • Nasal
  • Topical
  • Oral

          Distribution Channel

  • Hospital
  • Retail
  • Online

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Mometasone Furoate Industry - Regional Synopsis

North American Market Forecast

The mometasone furoate market in North America is expected to hold a share of 34% during the forecast period. The growth can be attributed to the growing number of awareness campaigns regarding psoriasis by the key players in the region. Also, the high prevalence of skin conditions like eczema and psoriasis in the region is propelling the growth of the market. For instance, in North America, 7.5 million individuals suffer from psoriasis every year. Furthermore, in North America, skincare and dermatological health are also becoming more popular, which has raised demand for products like mometasone furoate. New and improved mometasone formulations have also been made possible by the rapid advances in medical research and technology. Therefore, all these factors are contributing to the market growth of mometasone furoate in the region.

European Market Statistics

European mometasone furoate market is anticipated to hold a share of 27% by 2036. The increasing approvals for mometasone spray are driving the growth of the market. Also, the aging population in many European countries, raise the need for such products. Additionally, the prevalence of e-commerce and online pharmacies has made it easier for people to access and purchase mometasone products. Furthermore, the increasing investments in healthcare industries and the availability of advanced medical facilities in Europe have also supported the growth of the market.

Research Nester
Mometasone Furoate Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Mometasone Furoate Landscape

    • Perrigo Company plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bausch Health Companies Inc.
    • Glenmark Pharmaceuticals Limited
    • Vetoquinol USA
    • AstraZeneca plc
    • Intersect ENT


In The News

  • May 2021 - The world-renowned, research-driven pharmaceutical business Glenmark Pharmaceuticals Limited has announced the introduction of Ryaltris®-AZ Nasal Spray in India for the management of moderate to severe allergic rhinitis. As a market leader in the respiratory industry, Glenmark was the first in India to introduce a branded generic version for the treatment of allergic rhinitis at a reasonable price. Patients will now have access to a considerably more practical and affordable therapy alternative across the nation.
  • Sepetember 2022 - Simplera® (florfenicol, terbinafine, mometasone furoate) Otic Solution for Dogs is now available, according to Vetoquinol USA. It is the least expensive single-dose treatment for canine otitis externa linked to sensitive strains of bacteria (Staphylococcus pseudintermedius) and yeast (Malassezia pachydermatis). The first and only bioequivalent generic for Claro® (florfenicol, terbinafine, mometasone furoate) Otic Solution is called Simplera, and it has FDA approval.

Author Credits:  Smruti Ranjan, Rajrani Baghel

  • Report ID: 5507
  • Published Date: Jan 05, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing research & development activities, rising product launches, and growing cases of respiratory allergies are the major factors driving the growth of the mometasone furoate market.

The market size of mometasone furoate is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024 – 2036.

The major players in the market are Perrigo Company plc, Bausch Health Companies Inc., Glenmark Pharmaceuticals Limited, Vetoquinol USA, AstraZeneca plc, Intersect ENT, Kyorin Remedio Co., Ltd, Teikoku Seiyaku Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceuticals, and others.

The allergic rhinitis segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Mometasone Furoate Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying